Investor Relations Home

Webcast ImageWebcast
IRIDEX at Sidoti & Co. 2017 Spring Conference (Live)
03/29/17 at 12:00 p.m. ET
IRIDEX at Sidoti & Co. 2017 Spring Conference
Wednesday, March 29, 2017  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Profile
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$12.70
Change (%) Stock is Down 0.3 (2.31%)
Volume49,685
Data as of 03/27/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
03/15/17IRIDEX To Present At The Sidoti & Co. Spring 2017 Convention
MOUNTAIN VIEW, Calif., March 15, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the Sidoti & Co. Spring 2017 Convention in New York, NY. Iridex's management is scheduled to present on Wednesday, March 29, 2017 at 3:00pm ET. Interested parties can access the live webcast at www.IRIDEX.com. An archived presentation will also be available on the Company's website. About IRIDEX IRIDEX Corporation... 
Printer Friendly Version
03/08/17IRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook
Cyclo G6™ Glaucoma Laser Platform Fourth Quarter Revenue Up 67% Year-over-Year Record Revenue of $12.5 Million in the Fourth Quarter of 2016 MOUNTAIN VIEW, Calif., March 8, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months and full year ended December 31, 2016 and provided its full year 2017 financial outlook. Fourth Quarter and 2016 Financial Highlights Total revenue of $12.5 million for the... 
Printer Friendly Version
02/28/17IRIDEX Launches New FDA-Cleared Probe At The Annual American Glaucoma Society Meeting
The award winning CYCLO G6™ Glaucoma Laser System now offers a treatment with built-in transillumination MOUNTAIN VIEW, Calif., Feb. 28, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) is pleased to announce the availability of the G-Probe™ Illuminate, a new, FDA-cleared probe offering combined transillumination and laser fiber for targeted transscleral cyclophotocoagulation (CPC). The G-Probe Illuminate marks the third member of the family of probes powered by the CYCLO G6™ Glaucoma L... 
Printer Friendly Version
02/28/17IRIDEX To Present At 29th Annual Roth Conference
MOUNTAIN VIEW, Calif., Feb. 28, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the 29th Annual Roth Conference in Orange County, CA. Iridex's management is scheduled to present on Tuesday, March 14, 2017 at 9:30am PT. Interested parties can access the live webcast at www.IRIDEX.com. An archived presentation will be also available on the Company's website. About IRIDEX IRIDEX Corporation was founded in 1989 and is a worldw... 
Printer Friendly Version
Primary IR Contact
Lynn Lewis or Leigh Salvo
Phone: (415) 937-5404
E-mail: investors@iridex.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina